The Global CoagulationAnalyzers Market, By Product Type (Analyzers (Clinical LaboratoryAnalyzers, Point of Care Analyzers) and Consumables (Reagents & Kits,Point-of-care strips), By Test Type (Activated Partial Thromboplastin TimeTest, Prothrombin Time Test, D-Dimer Test, Fibrinogen Test, and OtherCoagulation Tests), and By End User (Hospitals, Diagnostic Laboratories,Research Institutes, and Others) was valued at US$ 2,481.78 million in 2017 andis projected to exhibit a CAGR of 9.7% over the forecast period (2017–2025).
Coagulation analyzers are used indiagnosis of bleeding disorders and thrombotic cases. The presence ofcoagulation analyzers these days are fully automated infuse with severaladvanced features to perform various functions such as cap piercing, primarytube sampling, dilution and automatic rerun. This ultimately, lowers totalcost, improves the quality of patient care and assures regulatory compliance inthe clinical laboratory. Instrumentation Laboratory — a Werfen company’sproduct — ACL TOP Family 50 series is designed for mid- to high-volume clinicallaboratories, which offers the most advanced automation and quality management,for routine to specialty assays, including clotting, chromogenic, andimmunological assays. These devices are highly sensitivity and offers accurateinformation and results thus, boosting the market growth of the coagulationanalyzers over the forecast period.
Browse 22 Market Data Tables and28 Figures spread through 150 Pages and in-depth TOC on "CoagulationAnalyzers Market, by Product Type (Analyzers (Clinical Laboratory Analyzers,Point of Care Analyzers) and Consumables (Reagents & Kits, Point-of-carestrips), by Test Type (Activated Partial Thromboplastin Time Test, ProthrombinTime Test, D-Dimer Test, Fibrinogen Test and Other Coagulation Tests) and byEnd User (Hospitals, Diagnostic Laboratories, Research Institutes and Others) -Global Forecast to 2025"
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1255
Companies are focusing ondeveloping next generation diagnostic analyzers to help to improve specificity,accuracy, and overall productivity without making the test expensive. They aredeveloping portable and small sized analyzers, in order to enhance their marketshare. These innovative analyzers offer the same results in less turnaroundtime making them hassle free and feasible for the operators. For instance, inJuly 2017, Sysmex America, Inc. launched its XN-L automated hematologyanalyzers in the U.S. to meet the demand of lower-volume hematology analyzers.Moreover, in 2014, Siemens Healthineer’s product Xprecia Stride CoagulationAnalyzer — a handheld device — received U.S. FDA approval for reliablemonitoring of oral anticoagulation therapy with warfarin, a vitamin Kantagonist. Moreover, in 2015, this same analyzer, received the Red Dot awardfor its design quality. The Red Dot Award is the largest and most recognizedinternational product competition in the world for product design quality.These factors are expected to augment growth of the coagulation analyzersmarket over the forecast period. Key players in the market are also engaged instrategic acquisitions and collaborations to increase their product portfoliosand to introduce new platform technologies. For instance, in January 2012,Roche entered into a strategic alliance with Technoclone — a reagent specialistin thrombosis and cardiovascular diagnostics based in Vienna, Austria — tofurther expand the company’s reagent portfolio in coagulation diagnostics. Thisin turn, will help the Roche to retain the market share in in-vitrodiagnostics. Furthermore, in August 2015, Abbott Laboratories entered into adefinitive agreement to acquire Omnilab — a middleware provider for clinicaldiagnostics and blood transfusion laboratories — to expand lab offerings tointernational markets outside the U.S.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/coagulation-analyzers-market-1255
Key Takeaways of the CoagulationAnalyzers Market:
The global coagulation analyzersmarket is expected to exhibit a CAGR of 9.7% over the forecast period (2017–2025).This is attributed to increasing adoption of these devices, as it providesaccurate results in low turnaround time.
Among product types, clinicallaboratory analyzers segment is expected to account for the largest share inthe global coagulation analyzers market over the forecast period. This isattributed to increasing use of these devices in hospitals for hematologicalanalysis of patients on a daily basis.
Among test types, prothrombintest segment accounted for the largest share in 2016, and this is owing toincreasing incidence of cardiovascular and blood related diseases. According toCenters for Disease Control & Prevention (CDC), 2014, annually, 790,000people in the U.S. suffer from heart attack, which indicates a potential needfor immediate diagnosis and need for the early treatment
Prevailing trend of outsourcinghemostasis tests to diagnostic centers for quick reports is expected to befactor for growth of the diagnostic laboratories segment over the forecastperiod.
Some of the major players in theglobal coagulation analyzers market are Siemens AG, Thermo Fisher ScientificInc., Hoffmann-La Roche Ltd., Instrumentation Laboratory, Sysmex Corporation,Beckman Coulter, Inc. (Danaher), Diamond Diagnostics, International TechnidyneCorporation, Nihon Kohden Corporation, and Alere Inc.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1255
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
